Clover Health Investments, Corp. (NASDAQ:CLOV) Shares Acquired by Marshall Wace LLP

Marshall Wace LLP lifted its stake in Clover Health Investments, Corp. (NASDAQ:CLOV - Free Report) by 167.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,769,765 shares of the company's stock after purchasing an additional 2,360,902 shares during the period. Marshall Wace LLP owned approximately 0.75% of Clover Health Investments worth $11,875,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Clover Health Investments by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 19,585,213 shares of the company's stock valued at $61,693,000 after buying an additional 386,499 shares in the last quarter. Geode Capital Management LLC raised its stake in Clover Health Investments by 1.1% in the 4th quarter. Geode Capital Management LLC now owns 4,882,461 shares of the company's stock valued at $15,387,000 after purchasing an additional 53,760 shares during the last quarter. State Street Corp lifted its holdings in Clover Health Investments by 65.0% in the 3rd quarter. State Street Corp now owns 2,189,380 shares of the company's stock valued at $6,174,000 after purchasing an additional 862,621 shares in the last quarter. Teacher Retirement System of Texas purchased a new stake in shares of Clover Health Investments during the fourth quarter worth about $2,769,000. Finally, Swiss National Bank raised its position in shares of Clover Health Investments by 6.3% in the fourth quarter. Swiss National Bank now owns 802,100 shares of the company's stock valued at $2,527,000 after buying an additional 47,700 shares during the last quarter. Hedge funds and other institutional investors own 19.77% of the company's stock.

Insider Activity at Clover Health Investments

In other news, CEO Brady Patrick Priest sold 75,000 shares of the business's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $3.68, for a total transaction of $276,000.00. Following the transaction, the chief executive officer now directly owns 2,418,151 shares of the company's stock, valued at approximately $8,898,795.68. The trade was a 3.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, General Counsel Karen Soares sold 52,500 shares of Clover Health Investments stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $3.80, for a total transaction of $199,500.00. Following the sale, the general counsel now directly owns 1,299,663 shares in the company, valued at $4,938,719.40. This trade represents a 3.88 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 327,500 shares of company stock worth $1,197,500. Corporate insiders own 22.28% of the company's stock.

Clover Health Investments Trading Down 1.2 %

Shares of Clover Health Investments stock traded down $0.04 during trading hours on Friday, reaching $3.43. The stock had a trading volume of 5,728,727 shares, compared to its average volume of 6,838,150. The firm has a market capitalization of $1.75 billion, a price-to-earnings ratio of -17.15 and a beta of 1.98. Clover Health Investments, Corp. has a 1 year low of $0.63 and a 1 year high of $4.87. The firm has a 50 day simple moving average of $3.71 and a two-hundred day simple moving average of $3.75.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group raised their price objective on Clover Health Investments from $4.20 to $4.50 and gave the stock a "buy" rating in a report on Monday, March 3rd.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.